Document is current
Any future updates will be listed below
-
Authors
Leventhal, Shanna S.
Shaia, Carl
Rao, Deepashri
Lewis, Matthew
Meade-White, Kimberly
Erasmus, Jesse H.
Feldmann, Heinz
Hawman, David W.
-
Funding
Funding for this research was provided by:
Division of Intramural Research
Medical CBRN Defense Consortium (MCDC2204–011, MCDC2204–011)
- License Information
-
More Information
Article History
Received: 3 September 2024
Accepted: 5 December 2024
First Online: 19 December 2024
Competing interests
: J.E. has an equity interest in HDT Bio. J.E. and A.K. are a co-inventor on U.S. patent application no. 62/993,307 “Compositions and methods for delivery of RNA” pertaining to formulations for RNA delivery. D.W.H., J.E., and H.F. are inventors on U.S. patent application number 63/365,015 “Replicating RNA vaccine for Crimean-Congo hemorrhagic fever virus” regarding the repRNA for use against CCHFV. All other authors declare no competing interests.
